CONSTITUTIVE NITRIC OXIDE SYNTHASES IN THE HEART FROM HYPERTROPHY TO FAILURE
- 27 February 2008
- journal article
- review article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 35 (4) , 483-488
Abstract
SUMMARY: Endogenous myocardial nitric oxide (NO) may modulate the transition from adaptive to maladaptive hypertrophy leading to heart failure. This review summarizes the information on the interrelations between the precise localization of NO synthases (NOS) and their regulatory functions within different compartments of the heart. In rodent models of pressure overload or myocardial infarction, the three NOS isoforms (NOS1, NOS2, NOS3) were shown to play a neutral, protective, or even adverse role in myocardial remodelling, depending on the NOS activity, the location of each NOS and their regulators. The analysis of conditions that modulate the expression of NOS1 and NOS3 in the heart according to physiopathological situations, indicated that, beside the level of total NOS activity, unique changes in NO compartmentation secondary to NOS1 or NOS3 subcellular location might be involved in the development of cardiac hypertrophy and failure. Thus, different circuits in NO‐signalling pathways in myocardium might be activated and this principle is a key to understand contradictions existing in NO biology in the heart. Unravelling the mechanisms behind the NO, NOS and cardiac function is still an ongoing challenge.Keywords
This publication has 73 references indexed in Scilit:
- Effects of sex differences on constitutive nitric oxide synthase expression and activity in response to pressure overload in ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Role of myocardial neuronal nitric oxide synthase in the development of cardiac hypertrophyJournal of Molecular and Cellular Cardiology, 2006
- Cardiac nitric oxide: Emerging role for nNOS in regulating physiological functionPharmacology & Therapeutics, 2005
- Role of Myocardial Neuronal Nitric Oxide Synthase–Derived Nitric Oxide in β-Adrenergic Hyporesponsiveness After Myocardial Infarction–Induced Heart Failure in RatCirculation, 2004
- Role of Myocardial Inducible Nitric Oxide Synthase in Contractile Dysfunction and β-Adrenergic Hyporesponsiveness in Rats With Experimental Volume-Overload Heart FailureCirculation, 2002
- Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted MiceScience, 2001
- Expression and Distribution of NOS1 and NOS3 in the Myocardium of Angiotensin II–Infused RatsHypertension, 2001
- Angiotensin-Converting Enzyme Inhibition Alters Nitric Oxide and Superoxide Release in Normotensive and Hypertensive RatsHypertension, 1997
- Cardiac weight in hypertension induced by nitric oxide synthase blockade.Hypertension, 1993
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980